Vera Therapeutics, Inc. Stock Issued During Period, Value, Employee Stock Purchase Plan
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- Vera Therapeutics, Inc. stock issued during period, value, employee stock purchase plan for the quarter ending 2026-03-31 was $1.44M, a 161.52% increase year-over-year.
- Vera Therapeutics, Inc. stock issued during period, value, employee stock purchase plan for the quarter ending 2025-09-30 was $766.00K, a 210.12% increase year-over-year.
- Vera Therapeutics, Inc. stock issued during period, value, employee stock purchase plan for the quarter ending 2025-03-31 was $551.00K, a 84.90% increase year-over-year.
- Vera Therapeutics, Inc. stock issued during period, value, employee stock purchase plan for the quarter ending 2024-09-30 was $247.00K, a 144.55% increase year-over-year.
- Vera Therapeutics, Inc. stock issued during period, value, employee stock purchase plan for fiscal 2025 was $1.32M, a 141.65% increase from fiscal 2024.
- Vera Therapeutics, Inc. stock issued during period, value, employee stock purchase plan for fiscal 2024 was $545.00K, a 98.18% increase from fiscal 2023.
- Vera Therapeutics, Inc. stock issued during period, value, employee stock purchase plan for fiscal 2023 was $275.00K, a 5.50% decline from fiscal 2022.
- Vera Therapeutics, Inc. stock issued during period, value, employee stock purchase plan for fiscal 2022 was $291.00K.
| Period end | Stock Issued During Period, Value, Employee Stock Purchase Plan 3 month | Stock Issued During Period, Value, Employee Stock Purchase Plan 12 month |
|---|---|---|
| 2026-03-31 | $1.44M 10-Q · filed 2026-08-10 | |
| 2025-12-31 | $1.32M 10-K · filed 2026-02-26 | |
| 2025-09-30 | $766.00K 10-Q · filed 2025-11-05 | |
| 2025-03-31 | $551.00K 10-Q · filed 2026-08-10 | |
| 2024-12-31 | $545.00K 10-K · filed 2026-02-26 | |
| 2024-09-30 | $247.00K 10-Q · filed 2025-11-05 | |
| 2024-03-31 | $298.00K 10-Q · filed 2025-11-05 | |
| 2023-12-31 | $275.00K 10-K · filed 2026-02-26 | |
| 2023-09-30 | $101.00K 10-Q · filed 2024-11-07 | |
| 2023-03-31 | $175.00K 10-Q · filed 2024-11-07 | |
| 2022-12-31 | $291.00K 10-K · filed 2024-03-27 | |
| 2022-09-30 | $122.00K 10-Q · filed 2023-11-09 | |
| 2022-03-31 | $169.00K 10-Q · filed 2023-11-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Harmony Biosciences Holdings, Inc. (HRMY) | United States | $2.399B | 11.67 |
| uniQure N.V. (QURE) | $2.416B | -4.93 | |
| SELLAS Life Sciences Group, Inc. (SLS) | United States | $2.420B | -91.87 |
| Mineralys Therapeutics, Inc. (MLYS) | United States | $2.353B | -6.82 |
| Nurix Therapeutics, Inc. (NRIX) | United States | $2.457B | -5.39 |
| Viridian Therapeutics, Inc.\DE (VRDN) | United States | $2.342B | -5.38 |
| SUPERNUS PHARMACEUTICALS, INC. (SUPN) | United States | $2.517B | -24.63 |
| Immunome Inc. (IMNM) | United States | $2.538B | -9.45 |
| Disc Medicine, Inc. (IRON) | United States | $2.553B | -11.40 |
| Zai Lab Ltd (ZLAB) | $2.241B | -113.34 |